Drug Shortage Report for KIDROLASE

Last updated on 2020-01-10 History
Report ID 101429
Drug Identification Number 01926438
Brand name KIDROLASE
Common or Proper name L-asparaginase
Company Name JAZZ PHARMACEUTICALS FRANCE SAS
Market Status CANCELLED POST MARKET
Active Ingredient(s) ASPARAGINASE
Strength(s) 10000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1 vial / pack
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2019-12-16
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-01-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 84 QUAI CHARLES DE GAULLE CITY ONE
LYON, AUVERGNE-RHONE-ALPES
FRANCE 69006
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-12-16 English Compare
v2 2019-12-16 English Compare
v3 2019-12-16 English Compare
v4 2019-12-16 French Compare
v5 2019-12-17 English Compare
v6 2019-12-24 English Compare
v7 2019-12-24 English Compare
v8 2019-12-24 French Compare
v9 2020-01-10 English Compare
v10 2020-01-10 French Compare

Showing 1 to 10 of 10